| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.44B | 40.86B | 32.92B | -26.79B | 32.99B | 30.56B |
| Gross Profit | 24.26B | 31.76B | 33.95B | 16.20B | 32.99B | 31.08B |
| EBITDA | 1.80B | 1.58B | 2.03B | -887.00M | 1.33B | 2.61B |
| Net Income | 722.00M | 683.00M | 1.08B | -1.07B | 416.00M | 2.06B |
Balance Sheet | ||||||
| Total Assets | 362.14B | 353.88B | 328.84B | 302.26B | 343.44B | 466.52B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 23.48B | 17.27B | 22.50B | 12.48B | 16.90B |
| Total Debt | 6.06B | 6.89B | 7.37B | 8.57B | 8.42B | 11.13B |
| Total Liabilities | 353.67B | 345.26B | 319.24B | 289.86B | 323.99B | 445.96B |
| Stockholders Equity | 8.41B | 8.30B | 8.79B | 12.09B | 19.20B | 19.55B |
Cash Flow | ||||||
| Free Cash Flow | 4.36B | 8.27B | -3.08B | 3.85B | 3.19B | 8.91B |
| Operating Cash Flow | 4.40B | 8.45B | -2.73B | 3.95B | 3.30B | 9.05B |
| Investing Cash Flow | -218.00M | 162.00M | -350.00M | 11.13B | -6.58B | -12.70B |
| Financing Cash Flow | -1.57B | -2.49B | -1.82B | -5.47B | -3.91B | -339.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £20.76B | 30.64 | 10.13% | 6.03% | -19.71% | -53.86% | |
71 Outperform | £29.10B | 11.53 | 20.51% | 1.56% | 37.94% | 291.37% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £7.28B | -11.48 | -49.24% | 7.48% | -34.62% | -19.20% | |
64 Neutral | £7.30B | 14.73 | 41.51% | 1.06% | -36.55% | ― | |
61 Neutral | £14.51B | 64.77 | 6.81% | 8.29% | -38.98% | -31.14% | |
61 Neutral | £6.73B | -115.41 | -1.53% | 7.09% | 9.86% | -134.41% |